Beekeepers anaphylaxis: successful immunotherapy covered by omalizumab
First published: 30 April 2007
*Children’s hospitalDepartment of Allergology and PneumologyJ.W. Goethe-UniversityTheodor Stern Kai 760590 Frankfurt am MainTel: +49 6963015732E-mail:
[email protected] No abstract is available for this article.
References
- 1
Hauck P,
Friedl K,
Kaufmehl K,
Urbanek R,
Forster J.
Subsequent insect stings in children with hypersensitivity to Hymenoptera.
J Ped
1994; 126: 185–190.
- 2
Brehler R,
Wolf H,
Kutting B,
Schnitker J,
Luger T.
Safety of a two-day ultrarush insect venom immunotherapy protocol in comparison with protocols of longer duration and involving a larger number of injections.
J Allergy Clin Immunol
2000; 105: 1231–1235.
- 3
Casale TB,
Busse WW,
Kline JN,
Ballas ZK,
Moss MH,
Townley RG
et al.
Omalizumab pre treatment decreases acute reactions after rush immunotherapy for ragweed-induced seasonal allergic rhinitis.
J Allergy Clin Immunol
2006; 117: 134–140.
